YC P26
FinalDose
Programmable DNA drug destroying all cancers, unlocking 80% of targets
About
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
Founders
- Li-Yao Huang
- Steven Lin
- Jeff Liu
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in FinalDose.
See family office activityIndustry & Focus
HealthcareTherapeuticsArtificial IntelligenceGene TherapyGenetic Engineering